It’s more clear than ever that the individual has become the most important stakeholder in the industry – and building a platform that they can depend on is how you change an outdated system.
Last year, I said that the value of what we’re building for customers at Hims & Hers isn’t restricted to borders. That’s even more true today as we announce we’ve agreed to acquire Eucalyptus, an international innovator in consumer health.1
Eucalyptus – the parent company of several consumer-beloved brands across Australia, the UK, Germany, Japan, and Canada – isn’t just a way to enter new markets for us. We've built a strong business in the US and established ourselves as a market leader. That momentum gives me confidence that our next step is expanding our brand abroad, where we can meet more people where they are with a care experience that feels not only simple, but human.
CEO Tim Doyle and his team at Eucalyptus are leaders in the industry because of their track record of efficiently entering new markets and as well as their customer-first approach, clinical rigor, simple digital experience, and local regulatory expertise. They approach healthcare just like we do: with the customer at the center of every decision. Combining their capabilities with our gold-standard platform means we can reach more people with care built for their unique needs, without ever sacrificing on the high standards they should expect. And as more biotech innovators, diagnostic companies, and leading drugmakers look for a partner that can help them reach more people with innovative new treatments, joining forces with Eucalyptus doesn’t just strengthen relationships that already exist – it will create opportunities for more in the future.
Healthcare challenges are global, and so is demand for simpler, more transparent, more personalized healthcare – but how that comes to life will look different for each market. That’s why we’ve always taken a local-led approach to global expansion, where we partner with experts to enter new markets in a way that makes room for the nuance of each territory.
We did that with ZAVA and Livewell, and as a result, we’ve built a robust international foundation. Eucalyptus has a track record of efficiently entering new markets, and together we plan to continue that pattern. Today puts us on the fast track to becoming the leading global consumer health platform, helping more people feel the impact of care that puts them at the center: something that feels like a luxury without costing like one.
I’m so excited to welcome Tim and his team to Hims & Hers after closing. Together, we’re expanding to make sure the day where everyone can access care that puts them in control of their health arrives sooner rather than later.
1 The acquisition is subject to customary closing conditions, and is expected to close during the middle of 2026.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained herein, including statements regarding the proposed transaction (the “Proposed Acquisition”), are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assume,” “may,” “will,” “likely,” “potential,” “projects,” “predicts,” “continue,” “goal,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “project,” “confidence,” “foundation,” “groundwork,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, the timing of the completion of the transaction (the “Closing”) and the integration of the Eucalyptus business, the satisfaction of all conditions to Closing, the plans for financing the transaction, and the anticipated impact of the transaction, including with respect to potential industry partnerships and international expansion plans and expectations. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained herein are based on the current expectations, assumptions and beliefs of Hims & Hers Health, Inc. (the “Company”). These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company’s control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: (i) the risk that the Proposed Acquisition may not be consummated in a timely manner, if at all; (ii) risks related to the diversion of management’s attention from the Company’s ongoing business operations; (iii) the effect of the announcement of the Proposed Acquisition on Eucalyptus’ and the Company’s business relationships (including, without limitation, customers and suppliers), operating results and business generally; (iv) risks related to the integration of the Eucalyptus business and the Company’s international expansion; (v) risks related to obtaining the requisite consents to the Proposed Acquisition, including, without limitation, the timing (including possible delays) and receipt of regulatory approvals from governmental entities (including any conditions, limitations or restrictions placed on these approvals) and the risk that one or more governmental entities may deny approval; (vi) regulatory, compliance and legal risks in the jurisdictions where the Company operates, including evolving regulatory frameworks; and (vii) risks related to the Company’s liquidity and capital allocation, including unanticipated demands on cash resources or changes in operating performance, as well as those factors described in the Risk Factors and other sections of the Company’s most recently filed Quarterly Report on Form 10-Q, the Company’s most recently filed Annual Report on Form 10-K, and other current and periodic reports the Company files from time to time with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize, or should any of the Company’s assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The Company undertakes no obligation (and expressly disclaims any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
